KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2016 - 2025)

Jazz Pharmaceuticals has reported Exchange Rate Effect over the past 14 years, most recently at $33000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $33000.0 for Q4 2025, up 101.44% from a year ago — trailing twelve months through Dec 2025 was $6.6 million (up 491.34% YoY), and the annual figure for FY2025 was $6.6 million, up 491.34%.
  • Exchange Rate Effect for Q4 2025 was $33000.0 at Jazz Pharmaceuticals, down from $203000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for JAZZ hit a ceiling of $4.9 million in Q4 2022 and a floor of -$5.4 million in Q3 2022.
  • Median Exchange Rate Effect over the past 5 years was -$304000.0 (2021), compared with a mean of -$170600.0.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 2332.35% in 2024 and later surged 709.22% in 2025.
  • Jazz Pharmaceuticals' Exchange Rate Effect stood at -$1.4 million in 2021, then skyrocketed by 456.06% to $4.9 million in 2022, then tumbled by 63.75% to $1.8 million in 2023, then tumbled by 227.95% to -$2.3 million in 2024, then soared by 101.44% to $33000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $33000.0 (Q4 2025), $203000.0 (Q3 2025), and $4.6 million (Q2 2025) per Business Quant data.